A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)  Marlene B. Goldman,

Slides:



Advertisements
Similar presentations
A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial  Richard H.
Advertisements

International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003  Karl G. Nygren,
Outdoor air pollution and human infertility: a systematic review
Grace Younes, M.D., Togas Tulandi, M.D., M.H.C.M. 
Impact of blastocyst transfer on offspring sex ratio and the monozygotic twinning rate: a systematic review and meta-analysis  Hye Jin Chang, M.D., Ph.D.,
How effective is in vitro fertilization, and how can it be improved?
Age at menarche: a predictor of diminished ovarian function?
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Infertility evaluation and treatment among women in the United States
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Michael M. Alper, M.D.  Fertility and Sterility 
A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial  Richard H.
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Hepatitis and reproduction
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Medical treatment of ectopic pregnancy: a committee opinion
In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors  Ahmad O. Hammoud, M.D.,
Aviad Cohen, M.D., Benny Almog, M.D., Togas Tulandi, M.D., M.H.C.M. 
Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain  David S. Guzick, M.D.,
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Prospective evaluation of luteal phase length and natural fertility
Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data  Michael L. Eisenberg, M.D., Shufeng Li,
Oocyte cryopreservation
Two interesting cases of ovarian pregnancy after in vitro fertilization–embryo transfer and its successful laparoscopic management  Selvaraj Priya, M.D.,
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials  Valeria M.S.
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS  Judy E. Stern,
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.
When do involuntarily infertile couples choose to seek medical help?
Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes  Aaron.
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study  Li Wei, Ph.D., Thomas MacDonald, M.D.,
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement    Fertility and Sterility  Volume 102,
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Interaction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women  Silvia Gamundi-Segura, M.Sc., Elena Torres-Perez,
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas  Chia-Lin Hsieh, M.D.,
Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles  Nicolás Garrido,
Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D
Marianne de Bennetot, M. D. , Benoît Rabischong, M. D. , Ph. D
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Pia Saldeen, M. D. , Ph. D. , Ahmed M. Abou-Setta, M. D
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above  Sigal Klipstein, M.D., Meredith.
Birth weight is associated with inner cell mass grade of blastocysts
First cesarean birth and subsequent fertility
Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series  Nanette L. Rollene,
Geographic distribution of reproductive endocrinology and infertility (REI) fellowships in the United States  Mary E. Abusief, M.D., Stacey A. Missmer,
HIV couples' anxiety and risk taking during ART
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Association of vitamin D intake and serum levels with fertility: results from the Lifestyle and Fertility Study  June L. Fung, Ph.D., Terryl J. Hartman,
Temporal and geospatial trends in male factor infertility with assisted reproductive technology in the United States from 1999–2010  Anobel Y. Odisho,
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Genetic evaluation procedures at sperm banks in the United States
Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr  Murat Arslan, M.D.,
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery.
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E
When is clomiphene or gonadotropin intrauterine insemination futile
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve  Norbert.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Presentation transcript:

A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)  Marlene B. Goldman, Sc.D., Kim L. Thornton, M.D., David Ryley, M.D., Michael M. Alper, M.D., June L. Fung, Ph.D., Mark D. Hornstein, M.D., Richard H. Reindollar, M.D.  Fertility and Sterility  Volume 101, Issue 6, Pages 1574-1581.e2 (June 2014) DOI: 10.1016/j.fertnstert.2014.03.012 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Screening, randomization, and enrollment of study couples. When we considered only the first two cycles of treatment, the results were identical except for two couples in the IVF arm who discontinued treatment after the first IVF cycle. a25 couples chose to discontinue treatment after a median of 4.0 cycles (interquartile range: 3–5 cycles) over a median duration of 12.2 months (interquartile range: 8.8–17.4 months). bThe median duration of follow-up for the couples we were unable to contact was 18.3 months (interquartile range: 12.0–21.4 months); the median duration was 17.5 months (interquartile range: 12.3–21.9 months) for couples who completed the follow-up period. Fertility and Sterility 2014 101, 1574-1581.e2DOI: (10.1016/j.fertnstert.2014.03.012) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 (A) Kaplan-Meier estimates of cumulative incidence of pregnancy leading to delivery of a live born for the controlled ovarian hyperstimulation arms combined versus the immediate IVF group. Analysis used a Cox proportional hazards model, P=.02. (B) Estimates with treatment cycle-independent pregnancies included, P=.02. HR = hazard ratio. Fertility and Sterility 2014 101, 1574-1581.e2DOI: (10.1016/j.fertnstert.2014.03.012) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions